Patients | Age | Sex | Symptoms | ENMG | Treatments | Evolution | |
Short and medium term | Long term (2 ans) | ||||||
1 | 2 | M | TPG (HS: 5) + P + M + BNI | AMAN | C + CBZ + PARA | RP (7j); DH (102j) | D |
2 | 2 | F | TPG (HS: 4) | AMAN | C | DH (18j) | D |
3 | 5 | M | TPS (HS: 2) + P | AMAN | C + CBZ | RP (5j); DH (32j) | HS: 2 |
4 | 4 | F | TPG (HS: 4) + P + PFP | AMAN | C + CBZ | RP (8j); DH (18j) | HS: 3 |
5 | 6 | M | TPG (HS: 4) + P + ANO | AMAN | C + CBZ | RP (8j); DH (22j) | D |
6 | 5 | M | TPG (HS: 4) + BPFP | AMSAN | C+ | DH (18j) | HS: 4 |
7 | 5 | M | TPG (HS: 4) + P | AMSAN | C + CBZ | RP (3j); DH (32j) | HS: 3 |
8 | 16 | M | TPG (HS: 4) + P + M | ADIP | C + CBZ + PARA | RP (5j); DH (15j) | HS: 0 |
9 | 10 | M | TPG (HS: 4) + BPFP | ADIP | C+ | DH (33j) | HS: 0 |
10 | 14 | F | TPG (HS: 4) + P | ADIP | C + CBZ | RP (5j); DH (16j) | HS: 0 |
11 | 4 | M | TPG (HS: 5) + BNI | ADIP | C | DH (42j) | HS: 0 |
12 | 8 | M | TPS (HS: 3) | ADIP | C+ | DH (10j) | HS: 1 |
13 | 12 | M | TPG (HS: 4) + P + M | ADIP | C + CBZ + PARA | RP (5j); DH (16j) | HS: 0 |
14 | 7 | F | TPG (HS: 4) + PFP | ADIP | C+ | DH (8j) | HS: 0 |
15 | 12 | M | TPG (HS: 4) + P | ADIP | C + CBZ | RP (3j); DH (15j) | HS: 0 |
16 | 9 | M | TPG (HS: 4) | ADIP | C+ | DH (3j) | HS: 1 |